Price $13.38 |
Market Cap
567.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.23
|
P/S
2.27
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-27.1K
|
FCF
-0.7
|
|
Op. Margin
-16.30%
|
Net Margin
-16.40%
|
ROE
-15.50%
|
ROI
-13.40%
|
|
ROA
-12.10%
|
EPS Growth
-93.20%
|
Current Ratio
6.0
|
Debt/Equity
8.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cytosorbents Corp (CTSO) | $2.37 | - | - | 61.1M | Strong Buy |
| Avalo Therapeutics Inc (AVTX) | $4.00 | - | - | 47.6M | Strong Buy |
| Biomerica Inc (BMRA) | $2.90 | - | - | 44.3M | Strong Buy |
| Humanigen Inc (HGEN) | $0.15 | - | - | 11.3M | Strong Buy |
| BioSig Technologies Inc (BSGM) | $0.74 | - | - | 20.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
